| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.07 | 0.08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |